DOCSLIB.ORG

NHSBT ODT Research Process Handbook Copy No: Effective Date: 19/02/2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NHSBT ODT Research Process Handbook Copy No: Effective Date: 19/02/2021 INF1393/5.1 – NHSBT ODT Research Process Handbook Copy No: Effective date: 19/02/2021 NHSBT ODT Research Process Handbook Controlled if copy number stated on document and issued by QA (Template Version 03/02/2020) Page 1 of 31 INF1393/5.1 – NHSBT ODT Research Process Handbook Copy No: Effective date: 19/02/2021 Contents Purpose of Document ............................................................................................................................. 4 Executive Summary ................................................................................................................................ 4 The Research Team ............................................................................................................................... 5 Consent or Authorisation for Research as taken by NHSBT’s Specialist Nurses .................................. 7 By Telephone or Video Call ................................................................................................................ 9 The National Allocation Scheme ............................................................................................................. 9 Hub Operations ................................................................................................................................... 9 Organs Available Through the Scheme ............................................................................................ 10 Anonymity.......................................................................................................................................... 11 Consent/Authorisation Restrictions ................................................................................................... 11 HTA B forms ...................................................................................................................................... 12 Islet and Hepatocyte Labs................................................................................................................. 12 Split Organs ...................................................................................................................................... 12 Centre-Specific Studies ......................................................................................................................... 14 Novel Therapeutic Interventions ....................................................................................................... 14 Change Control, Risk Assessment and Standard Operating Procedure (SOP) Creation ................ 14 Designated Individual (DI) Approval ................................................................................................. 14 Operational Prioritisation and Specialist Nurse Training .................................................................. 15 Qualitative Studies ................................................................................................................................ 15 Service Evaluations ............................................................................................................................... 16 Early Engagement ................................................................................................................................. 16 Writing a protocol .............................................................................................................................. 16 Immortalised Cell Lines ..................................................................................................................... 17 Approval Routes and Documentation ................................................................................................... 17 External Approvals (e.g. REC and HRA) .......................................................................................... 17 Blank Copies of the NHSBT Consent/Authorisation Form ............................................................ 17 Letters of Support .......................................................................................................................... 17 Clinical Trial Management ............................................................................................................. 17 NHSBT Approvals ............................................................................................................................. 18 RINTAG ......................................................................................................................................... 18 Go Live .......................................................................................................................................... 19 Sponsorship .......................................................................................................................................... 20 NHSBT Sponsorship ......................................................................................................................... 20 Study Ranking ....................................................................................................................................... 21 Agreements with NHSBT ...................................................................................................................... 21 Appeals ................................................................................................................................................. 21 Once a Study Is Live ............................................................................................................................. 22 Controlled if copy number stated on document and issued by QA (Template Version 03/02/2020) Page 2 of 31 INF1393/5.1 – NHSBT ODT Research Process Handbook Copy No: Effective date: 19/02/2021 EOS Mobile access ........................................................................................................................... 22 Copies of the Consent/Authorisation Form ....................................................................................... 22 Progress Reports .............................................................................................................................. 22 Resubmissions .................................................................................................................................. 22 Changes to Contact Details .............................................................................................................. 22 Pausing a Study ................................................................................................................................ 22 Finishing a Study ............................................................................................................................... 23 Useful Websites .................................................................................................................................... 24 Contact Details ...................................................................................................................................... 24 Appendix 1 – Acronyms and Definitions ............................................................................................... 25 Appendix 2 – Legal Requirements for Removal of Organs and Tissues from Organ Donors .............. 27 Removal of tissue/organs for research purposes ............................................................................. 27 Local Guidance ................................................................................................................................. 27 Consenting/authorising to use human tissue in Scheduled/Other Purposes or Novel Therapies .... 27 Appendix 3 – Responsibilities ............................................................................................................... 28 Appendix 4 – Transportation of Organs for Scheduled/Other Purposes .............................................. 31 Controlled if copy number stated on document and issued by QA (Template Version 03/02/2020) Page 3 of 31 INF1393/5.1 – NHSBT ODT Research Process Handbook Copy No: Effective date: 19/02/2021 Purpose of Document The purpose of this document is to outline the procedure for setting up studies and implementing novel therapies/technologies that involve NHSBT’s organ and tissue donation, retrieval and/or transplantation processes. It is provided to guide researchers wishing to: Obtain access to organ donors and/or organs, tissues and cells from donors for research purposes Set up qualitative studies with members of the wider Organ and Tissue Donation and Transplantation (OTDT) team such as Specialist Nurses or National Organ Retrieval Service (NORS) team members Set up service evaluations appraising the OTDT process Test and/or implement novel therapies/technologies (such as novel transplants) This document contains details of the various approvals, documents, and stakeholder engagement required to gain approval from NHSBT, via the Research, Innovation and Novel Technologies Advisory Group (RINTAG), and where appropriate the OTDT Senior Management Team (SMT). The term “relevant material” is used throughout this document to refer to organs, tissues and cells. Please refer to the Human Tissue Authority (HTA) website for more information about what is and isn’t “relevant material”. The OTDT Study Approval process has been established to provide assurance to NHSBT that donated “relevant material” is only supplied to research studies that have gained all the appropriate approvals, and that NHSBT’s operational
Load more

Recommended publications
  • NHS Blood and Transplant Annual Report and Accounts 2019/20
    2019/20 Annual Report HC 773 and Accounts SG/2020/102 2 | ANNUAL REPORT AND ACCOUNTS 2019/20 NHS Blood and Transplant Annual Report and Accounts 2019/20 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 17 September 2020 HC 773 SG/2020/102 ANNUAL REPORT AND ACCOUNTS 2019/20 | 3 © Crown copyright 2020 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3/ Where we have identified any third-party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at: www.gov.uk/official-documents. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, 500 North Bristol Park, Filton, BS34 7QH. ISBN 978-1-5286-2141-0 CCS0920201056 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office Contents Introduction from the Chair ....................................... 6 Corporate governance statement ........................... 57 Overview ................................................................. 8 Parliamentary accountability ................................... 64 Our
    [Show full text]
  • Transfusion 2024 a Five-Year Plan for Clinical and Laboratory Transfusion
    National Blood Transfusion Committee and NHS Blood and Transplant Transfusion 2024 A Five-year Plan for Clinical and Laboratory Transfusion P1 | Transfusion 2024 National Blood Transfusion Committee and NHS Blood and Transplant FOREWORD Transfusion 2024 is a call to action and provides a plan for us all to push boundaries and achieve the best possible transfusion care for all patients. Transfusion 2024 also marks a defining moment for how the National Blood Transfusion Committee and NHS Blood and Transplant worked together in an inclusive manner. We listened to the diverse views, expertise and experience of our stakeholders, and we are fully committed to continue in this way to deliver Transfusion 2024. Professor Cheng Hock Toh We are both excited about its ambition to improve safety, Chair, National Blood Transfusion Committee experience and outcomes for our patients. This lies at the very heart of modern medicine and we are determined that Transfusion 2024 sets an exemplar of how clinical, laboratory, scientific and technological advances can be embraced efficiently and translated effectively. Its delivery will challenge us all, but we are confident of success because the transfusion community has shown itself to be resilient and adaptable, especially during COVID-19. We are proud to be part of the transfusion community in these uncertain and frightening times; where innovation Dr Gail Miflin and resilience has supported donors, healthcare workers Chief Medical Officer, NHS Blood and Transplant and patients to consolidate the NHS as an exemplary healthcare system that we all can be proud of. Acknowledgements: Our confidence also stems from the rich history of A summary of stakeholders involved pioneering transfusion medicine in the UK, which has in Transfusion 2024 are detailed provided such solid foundations to further build upon.
    [Show full text]
  • 2019/19 Annual Report and Accounts
    Our 2018/19 Annual Report and Accounts HC2301 SG/2019/86 Annual Report and Accounts 2018/19 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 09 July 2019 HC2301 SG/2019/86 © Crown copyright 2019 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government- licence/version/3/ Where we have identified any third-party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at: www.gov.uk/official-documents. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, 500 North Bristol Park, Filton, BS34 7QH. ISBN 978-1-5286-1252-4 CCS – CCS0419046238 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office CONTENTS – THE ANNUAL REPORT AND ACCOUNTS 2018/19 Performance Report ……………………………………………………….……….… 7 Chief Executive’s Foreword ……………………………………………………..…… 9 Performance Analysis………………………………………………………………… 13 Accountability report …………………………………………………………………. 27 Corporate Governance Report…………………………………………….………… 29 Remuneration and Staff Report………………………… ……………………….…. 49 Parliamentary Accountability
    [Show full text]
  • Triennial Review of NHS Blood and Transplant (NHSBT)
    Triennial Review of NHS Blood and Transplant (NHSBT) Review Report September 2016 Title: Triennial Review of NHS Blood and Transplant; Review Report Authors: Adam McMordie (Lead Reviewer), and Paul McCormack (Assistant Lead Reviewer) – Strategy, System Oversight and Performance Directorate, Finance and Group Operations (17152) Document Purpose: Corporate Report Publication date: 15 September 2016 Target audience: Voluntary groups, Community groups, Charities, Civil society, Advocacy or support organisations, Clinicians, Managers, Commissioners, Directors of Public Health, Pharmacists, Doctors, Midwives, Healthcare scientists, Foundation Trusts, NHS Commissioning Board, Clinical Commissioning Groups, Regulatory body, Academic/ Professional institution, Trade union, General public, Patients, Patients, Service users, Suppliers. Contact details: Triennial Review Programme Team Department of Health 220 Richmond House 79 Whitehall London SW1A 2NS [email protected] You may re-use the text of this document (not including logos) free of charge in any format or medium, under the terms of the Open Government Licence. To view this licence, visit www.nationalarchives.gov.uk/doc/open-government-licence/ © Crown copyright Published to gov.uk, in PDF format only. www.gov.uk/dh 2 Prepared by Lead Reviewer and Assistant Lead Reviewer, Strategy, System Oversight and Performance Directorate, DH 3 Contents Review Report ........................................................................................................................... 1 Contents
    [Show full text]
  • Filton Blood Centre
    Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Filton Blood Centre North Bristol Park, Filton, Bristol, BS34 7QH Tel: 01179217200 Date of Inspections: 29 January 2014 Date of Publication: February 28 January 2014 2014 We inspected the following standards as part of a routine inspection. This is what we found: Respecting and involving people who use Met this standard services Consent to care and treatment Met this standard Care and welfare of people who use services Met this standard Cleanliness and infection control Met this standard Supporting workers Met this standard Assessing and monitoring the quality of service Met this standard provision | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 1 Details about this location Registered Provider NHS Blood and Transplant Overview of the Filton Blood Centre in Bristol provides specialist scientific service and laboratory services, which the Commission do not regulate. The service collects whole blood and blood component products from voluntary donors and then delivers these to the NHS and other UK health services as directed. We regulate and inspect this part of the service. This inspection was carried out in the Southmead Blood Donor Centre, a permanent site based in the grounds of Southmead Hospital, and one mobile blood donor session. Type of services Acute services with overnight beds Blood and Transplant service Diagnostic and/or screening service Regulated activities Diagnostic and screening procedures Management of supply of blood and blood derived products Treatment of disease, disorder or injury | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 2 Contents When you read this report, you may find it useful to read the sections towards the back called 'About CQC inspections' and 'How we define our judgements'.
    [Show full text]
  • Controlled If Copy Number Stated on Document and Issued by QA (Template Version 03/02/2020) Page 1 of 45
    INF136/8 – User Guide for Histocompatibility and Immunogenetics Diagnostics Services Copy No: Effective date: 15/11/2020 HISTOCOMPATIBILITY AND IMMUNOGENETICS DIAGNOSTIC SERVICES USER GUIDE Controlled if copy number stated on document and issued by QA (Template Version 03/02/2020) Page 1 of 45 CONTROLLED INF136/8 – User Guide for Histocompatibility and Immunogenetics Diagnostics Services Copy No: Effective date: 15/11/2020 Contents CONTENTS ............................................................................................................................................. 2 LIST OF FIGURES .................................................................................................................................. 4 LIST OF TABLES ................................................................................................................................... 4 CHAPTER 1: GENERAL INFORMATION.............................................................................................. 5 1.1 THIS GUIDE ................................................................................................................................. 5 1.2 QUALITY STATEMENT ............................................................................................................... 5 1.3 COMPLIMENTS AND COMPLAINTS ......................................................................................... 5 CHAPTER 2: H&I LABORATORIES AND MANAGEMENT ................................................................. 6 2.1.1 OUT OF HOURS .....................................................................................................................
    [Show full text]
  • NHS Blood and Transplant Annual Report and Accounts 2016/17
    NHS Blood and Transplant Annual Report and Accounts 2016/17 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 6 July 2017 HC35 SG/2017/75 NHS Blood and Transplant Annual Report and Accounts 2016/17 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 6 July 2017 HC35 SG/2017/75 © NHS Blood and Transplant copyright 2017 The text of this document (this excludes, where present, the Royal Arms and all departmental or agency logos) may be reproduced free of charge in any format or medium provided that it is reproduced accurately and not in a misleading context. The material must be acknowledged NHS Blood and Transplant copyright and the document title specified. Where third party material has been identified, permission from the respective copyright holder must be sought. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, Oak House, Reeds Crescent, Watford, Hertfordshire, WD24 4QN. This publication is available at https://www.gov.uk/government/publications Print ISBN 9781474142335 Web ISBN 9781474142342 ID 22031709 07/17 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the Williams Lea Group on behalf of the Controller of Her Majesty’s Stationery Office CONTENTS - THE ANNUAL REPORT AND ACCOUNTS 2016/17 THE PERFORMANCE REPORT Overview………………………………………………………………………………………….
    [Show full text]
  • 2019/20 Annual Report and Accounts
    2019/20 Annual Report HC 773 and Accounts SG/2020/102 2 | ANNUAL REPORT AND ACCOUNTS 2019/20 NHS Blood and Transplant Annual Report and Accounts 2019/20 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 17 September 2020 HC 773 SG/2020/102 ANNUAL REPORT AND ACCOUNTS 2019/20 | 3 © Crown copyright 2020 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3/ Where we have identified any third-party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at: www.gov.uk/official-documents. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, 500 North Bristol Park, Filton, BS34 7QH. ISBN 978-1-5286-2141-0 CCS0920201056 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office Contents Introduction from the Chair ....................................... 6 Corporate governance statement ........................... 57 Overview ................................................................. 8 Parliamentary accountability ................................... 64 Our
    [Show full text]
  • Item 5.7 Agchc 14 29 Data Access Policy V1 4
    AGChC(14)29 NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE POLICY FOR ACCESS TO DATA AND INFORMATION THROUGH STATISTICS & CLINICAL STUDIES 1 Introduction and scope In order to fulfil the 2005 Directions (see http://www.odt.nhs.uk/odt/regulation/NHSBT-directions- 2005/), NHS Blood and Transplant (NHSBT) collects, records and analyses data that can be anonymised and/or personally identifiable or sensitive concerning potential and actual organ donors, patients registered for transplant, transplant recipients including long-term follow-up information and individuals registering on the NHS Organ Donor Register. Data collected nationally enables NHSBT to fulfil its statutory obligations with regard to the effective use of organs, equitable organ allocation and performance monitoring of transplant centres in terms of patient and graft outcomes as well as support patients and the public with relevant information in a timely and transparent manner NHSBT receives many requests for data on activity and outcomes to address questions of interest to colleagues engaged in transplantation, the media and other stakeholders. NHSBT is keen to make data available and support the public and health care professionals to access data in a timely and appropriate manner. This policy clarifies how data held by NHSBT can be accessed and used by individuals or groups within NHSBT, with advisory roles to NHSBT, within the wider NHS, from other organisations with an interest in organ donation and transplantation and by members of the public
    [Show full text]